DOGWOOD THERAPEUTICS INC (DWTX) Stock Price, Quote, News and Overview
NASDAQ:DWTX - Nasdaq - US92829J2033 - Common Stock - Currency: USD
DWTX Quote, Performance and Key Statistics
5.36
-0.52 (-8.84%)
The current stock price of DWTX is 5.36 USD. In the past month the price decreased by -59.85%.
DWTX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About DWTX
Company Profile
Dogwood Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Alpharetta, Georgia and currently employs 4 full-time employees. The company went IPO on 2020-12-17. Dogwood Therapeutics, Inc., formerly Virios Therapeutics, Inc., is focused on the clinical development of three assets, Halneuron, IMC-1, and IMC-2. Halneuron is in Phase 2b development as a non-opioid, Nav 1.7 inhibitor, to treat the neuropathic pain associated with chemotherapy treatment. Halneuron is an injectable formulation of Tetrodotoxin, a novel small molecule with action exclusively on the peripheral nervous system. IMC-2 (valacyclovir + celecoxib) is in Phase 2 development as a combination antiviral treatment for Long-COVID (LC). IMC-1 (famciclovir (FM) + celecoxib) is Phase 3 development ready as a combination antiviral treatment for FM. IMC-1 has been granted fast track designation by the FDA. IMC-1 is a novel, proprietary, fixed dose combination of famciclovir and celecoxib designed to synergistically suppress herpes virus replication, with the end goal of reducing virally promoted disease symptoms.
Company Info
DOGWOOD THERAPEUTICS INC
44 Milton Avenue
Alpharetta GEORGIA US
Employees: 4
Company Website: https://dwtx.com/
Investor Relations: http://ir.virios.com
Phone: 18666208655
DOGWOOD THERAPEUTICS INC / DWTX FAQ
What is the stock price of DOGWOOD THERAPEUTICS INC today?
The current stock price of DWTX is 5.36 USD. The price decreased by -8.84% in the last trading session.
What is the ticker symbol for DOGWOOD THERAPEUTICS INC stock?
The exchange symbol of DOGWOOD THERAPEUTICS INC is DWTX and it is listed on the Nasdaq exchange.
On which exchange is DWTX stock listed?
DWTX stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for DOGWOOD THERAPEUTICS INC stock?
8 analysts have analysed DWTX and the average price target is 54.91 USD. This implies a price increase of 924.44% is expected in the next year compared to the current price of 5.36. Check the DOGWOOD THERAPEUTICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is DOGWOOD THERAPEUTICS INC worth?
DOGWOOD THERAPEUTICS INC (DWTX) has a market capitalization of 7.13M USD. This makes DWTX a Nano Cap stock.
How many employees does DOGWOOD THERAPEUTICS INC have?
DOGWOOD THERAPEUTICS INC (DWTX) currently has 4 employees.
Should I buy DOGWOOD THERAPEUTICS INC (DWTX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of DWTX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of DWTX, evaluating the profitability, health, valuation and growth aspects
- DOGWOOD THERAPEUTICS INC (DWTX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- DOGWOOD THERAPEUTICS INC (DWTX) Sales and EPS estimates to see what analysts future expectations are.
- DOGWOOD THERAPEUTICS INC (DWTX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- DOGWOOD THERAPEUTICS INC (DWTX) Insider and Institutional Ownership to learn about the owners and their transactions.
- DOGWOOD THERAPEUTICS INC (DWTX) Stock Chart to make your own analysis
- DOGWOOD THERAPEUTICS INC (DWTX) Latest news and press-releases to stay up to date.
Does DOGWOOD THERAPEUTICS INC (DWTX) stock pay dividends?
DWTX does not pay a dividend.
When does DOGWOOD THERAPEUTICS INC (DWTX) report earnings?
DOGWOOD THERAPEUTICS INC (DWTX) will report earnings on 2025-02-26, after the market close.
What is the Price/Earnings (PE) ratio of DOGWOOD THERAPEUTICS INC (DWTX)?
DOGWOOD THERAPEUTICS INC (DWTX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-6.55).
What is the Short Interest ratio of DOGWOOD THERAPEUTICS INC (DWTX) stock?
The outstanding short interest for DOGWOOD THERAPEUTICS INC (DWTX) is 8.31% of its float. Check the ownership tab for more information on the DWTX short interest.
DWTX Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to DWTX.
DWTX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to DWTX. DWTX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
DWTX Financial Highlights
Over the last trailing twelve months DWTX reported a non-GAAP Earnings per Share(EPS) of -6.55. The EPS increased by 20.61% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -145.66% | ||
| ROE | -168.89% | ||
| Debt/Equity | 0 |
DWTX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to DWTX. The Buy consensus is the average rating of analysts ratings from 8 analysts.